Cargando…
Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood–Brain Barrier
ABCB1 and ABCG2 work together at the blood–brain barrier (BBB) to limit brain distribution of dual ABCB1/ABCG2 substrates. In this pilot study we used positron emission tomography (PET) to assess brain distribution of two model ABCB1/ABCG2 substrates ([(11)C]elacridar and [(11)C]tariquidar) in healt...
Autores principales: | Bauer, M, Römermann, K, Karch, R, Wulkersdorfer, B, Stanek, J, Philippe, C, Maier‐Salamon, A, Haslacher, H, Jungbauer, C, Wadsak, W, Jäger, W, Löscher, W, Hacker, M, Zeitlinger, M, Langer, O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979595/ https://www.ncbi.nlm.nih.gov/pubmed/26940368 http://dx.doi.org/10.1002/cpt.362 |
Ejemplares similares
-
ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure
por: El Biali, Myriam, et al.
Publicado: (2021) -
Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study
por: Bauer, Martin, et al.
Publicado: (2015) -
Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography
por: Wulkersdorfer, Beatrix, et al.
Publicado: (2019) -
Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography
por: Hernández Lozano, Irene, et al.
Publicado: (2019) -
Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects
por: Bauer, Martin, et al.
Publicado: (2020)